Total: 448 results found.
Page 7 of 23
Cannabis Science Recaps "Your Money's Worth" Radio Interview: The Company Spoke of Its Market Prioritization, Progress to-Date, and Strategic Planning Moving Forward
Created on 2018-06-13 18:53:45
Analyst Initiates Coverage on Cannabis Science w/ Accumulate Recommendation and $0.10 PPS Target as Company Advances Additional Product Lines in California and Gears Up for Animal Healthcare Entry Through Equi-Pharm
Created on 2018-06-13 18:52:19
Cannabis Science (CBIS) Announces Positive Results in California Test Run of Its Pure Decarboxylated CO2 Oil (PDCO) Released Through the Cannabis Science Research Foundation (CSRF) to 15 Dispensaries & Several Less Fortunate, Self-Medicating Patients for
Created on 2018-06-13 18:51:22
Cannabis Science Releases Cannabinoid-Formulated Capsule Product Line in California; Initial Capsule Formulations Released Are CBD, Indica, and Sativa
Created on 2018-06-13 18:50:30
Cannabis Science Enters Select, New High-Dosage Product Line of CBD, Sativa, and Indica Capsules Into the Industry-Famous Emerald Cup Event This Weekend in Santa Rosa, CA
Created on 2018-06-13 18:47:22
After Successful Formulation Work, Cannabis Science Follows Through With a Full Clinical Drug Development Agreement With ImmunoClin to Deliver GMP Quality Pre-Clinical Data to Enter CS-NEURO-1 Into a Phase I Human Study in Europe
Created on 2018-06-13 18:40:09
After Successful Formulation Work, Cannabis Science Follows Through With a Full Clinical Drug Development Agreement With ImmunoClin to Deliver GMP Quality Pre-Clinical Data to Enter CS-NEURO-1 Into a Phase I Human Study in Europe
Created on 2018-06-13 18:39:06
Cannabis Science (OTC PINK: CBIS) to Be a Featured Guest on "Your Money's Worth" National Radio Show, Tonight From 5-7 PM (EST) on 1470 AM, WWNN Radio South Florida, as Well as Live Internet Streaming
Created on 2018-06-13 18:38:05
Cannabis Science Releases Forward-Looking Clinical Guidance for 2016; the Company Is Positioned to Expand Clinical Trials Into the New Year
Created on 2018-06-13 18:33:26
Cannabis Science Announces Update on Issuance of Dividends
Created on 2018-06-13 18:27:58
Cannabis Science Announces Update on Issuance of Dividends
Created on 2018-06-13 18:26:02
CBIS & Purple Haze Properties Launch "Jimi's Meds" eCommerce Website Powered by Cannabis Science and Showcased This Weekend at the High Times Cannabis Cup in Southern California
Created on 2018-06-12 23:15:48
Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board
Created on 2018-06-12 23:14:49
Purple Haze Properties (PHP) & Cannabis Science (CBIS) Announce Successful Launch of Hendrix-Themed Cannabis Theraputic Products
Created on 2018-06-12 23:13:41
CBIS Set to Partner and Power the New iPhone APP, "The Joey Network", Just Released by Mieko Hester-Perez, SAB Member, Providing Patients and Families a Wealth of Autism Resources and Cannabis Treatment Options
Created on 2018-06-12 23:12:29
In an Unprecedented Move, Cannabis Science President & CEO, Mr. Raymond C. Dabney, to Gift His Personal Shares to Shareholders to Replace Both Previously Announced Dividends, to Personally Complete Promised Payouts
Created on 2018-06-12 23:11:36
Cannabis Science CEO Plans to Expand Share Gifts to ALL Shareholders up to March 31, 2016, Thus Including ALL Old & New Shareholders up to the New Cutoff Date; Issues Preliminary Instructions for Shareholders of Record Dates to Receive Gifted Shares
Created on 2018-06-12 23:10:23
Cannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive Results With Its CBD-Based Epilepsy Formulation
Created on 2018-06-12 23:09:31